212 related articles for article (PubMed ID: 34329686)
1. Generation of microRNA-378a-deficient hiPSC as a novel tool to study its role in human cardiomyocytes.
Martyniak A; Andrysiak K; Motais B; Coste S; Podkalicka P; Ferdek P; Stępniewski J; Dulak J
J Mol Cell Cardiol; 2021 Nov; 160():128-141. PubMed ID: 34329686
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated iron homeostasis in dystrophin-deficient cardiomyocytes: correction by gene editing and pharmacological treatment.
Andrysiak K; Machaj G; Priesmann D; Woźnicka O; Martyniak A; Ylla G; Krüger M; Pyza E; Potulska-Chromik A; Kostera-Pruszczyk A; Łoboda A; Stępniewski J; Dulak J
Cardiovasc Res; 2024 Feb; 120(1):69-81. PubMed ID: 38078368
[TBL] [Abstract][Full Text] [Related]
3. Absence of full-length dystrophin impairs normal maturation and contraction of cardiomyocytes derived from human-induced pluripotent stem cells.
Pioner JM; Guan X; Klaiman JM; Racca AW; Pabon L; Muskheli V; Macadangdang J; Ferrantini C; Hoopmann MR; Moritz RL; Kim DH; Tesi C; Poggesi C; Murry CE; Childers MK; Mack DL; Regnier M
Cardiovasc Res; 2020 Feb; 116(2):368-382. PubMed ID: 31049579
[TBL] [Abstract][Full Text] [Related]
4. Exon skipping and gene transfer restore dystrophin expression in human induced pluripotent stem cells-cardiomyocytes harboring DMD mutations.
Dick E; Kalra S; Anderson D; George V; Ritso M; Laval SH; Barresi R; Aartsma-Rus A; Lochmüller H; Denning C
Stem Cells Dev; 2013 Oct; 22(20):2714-24. PubMed ID: 23829870
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of intracellular Ca
Sato M; Shiba N; Miyazaki D; Shiba Y; Echigoya Y; Yokota T; Takizawa H; Aoki Y; Takeda S; Nakamura A
Biochem Biophys Res Commun; 2019 Nov; 520(1):179-185. PubMed ID: 31585729
[TBL] [Abstract][Full Text] [Related]
6. Modeling Duchenne Muscular Dystrophy Cardiomyopathy with Patients' Induced Pluripotent Stem-Cell-Derived Cardiomyocytes.
Eisen B; Binah O
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240001
[TBL] [Abstract][Full Text] [Related]
7. Compromised diabetic heart function is not affected by miR-378a upregulation upon hyperglycemia.
Florczyk-Soluch U; Polak K; Sabo R; Martyniak A; Stępniewski J; Dulak J
Pharmacol Rep; 2023 Dec; 75(6):1556-1570. PubMed ID: 37851320
[TBL] [Abstract][Full Text] [Related]
8. Human iPSC model reveals a central role for NOX4 and oxidative stress in Duchenne cardiomyopathy.
Duelen R; Costamagna D; Gilbert G; De Waele L; Goemans N; Desloovere K; Verfaillie CM; Sipido KR; Buyse GM; Sampaolesi M
Stem Cell Reports; 2022 Feb; 17(2):352-368. PubMed ID: 35090586
[TBL] [Abstract][Full Text] [Related]
9. Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency.
Pioner JM; Santini L; Palandri C; Langione M; Grandinetti B; Querceto S; Martella D; Mazzantini C; Scellini B; Giammarino L; Lupi F; Mazzarotto F; Gowran A; Rovina D; Santoro R; Pompilio G; Tesi C; Parmeggiani C; Regnier M; Cerbai E; Mack DL; Poggesi C; Ferrantini C; Coppini R
Front Physiol; 2022; 13():1030920. PubMed ID: 36419836
[TBL] [Abstract][Full Text] [Related]
10. Targeted addition of mini-dystrophin into rDNA locus of Duchenne muscular dystrophy patient-derived iPSCs.
Zeng B; Zhou M; Liu B; Shen F; Xiao R; Su J; Hu Z; Zhang Y; Gu A; Wu L; Liu X; Liang D
Biochem Biophys Res Commun; 2021 Mar; 545():40-45. PubMed ID: 33540285
[TBL] [Abstract][Full Text] [Related]
11.
Jimenez-Vazquez EN; Arad M; Macías Á; Vera-Pedrosa ML; Cruz FM; Gutierrez LK; Cuttitta AJ; Monteiro da Rocha A; Herron TJ; Ponce-Balbuena D; Guerrero-Serna G; Binah O; Michele DE; Jalife J
Elife; 2022 Jun; 11():. PubMed ID: 35762211
[TBL] [Abstract][Full Text] [Related]
12. Physiological stress improves stem cell modeling of dystrophic cardiomyopathy.
Fullenkamp DE; Willis AB; Curtin JL; Amaral AP; Dittloff KT; Harris SI; Chychula IA; Holgren CW; Burridge PW; Russell B; Demonbreun AR; McNally EM
Dis Model Mech; 2024 Jun; 17(6):. PubMed ID: 38050701
[TBL] [Abstract][Full Text] [Related]
13. Cardiomyocyte-produced miR-339-5p mediates pathology in Duchenne muscular dystrophy cardiomyopathy.
Gartz M; Beatka M; Prom MJ; Strande JL; Lawlor MW
Hum Mol Genet; 2021 Nov; 30(23):2347-2361. PubMed ID: 34270708
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiological abnormalities in induced pluripotent stem cell-derived cardiomyocytes generated from Duchenne muscular dystrophy patients.
Eisen B; Ben Jehuda R; Cuttitta AJ; Mekies LN; Shemer Y; Baskin P; Reiter I; Willi L; Freimark D; Gherghiceanu M; Monserrat L; Scherr M; Hilfiker-Kleiner D; Arad M; Michele DE; Binah O
J Cell Mol Med; 2019 Mar; 23(3):2125-2135. PubMed ID: 30618214
[TBL] [Abstract][Full Text] [Related]
15. Stem Cell-Derived Cardiomyocytes and Beta-Adrenergic Receptor Blockade in Duchenne Muscular Dystrophy Cardiomyopathy.
Kamdar F; Das S; Gong W; Klaassen Kamdar A; Meyers TA; Shah P; Ervasti JM; Townsend D; Kamp TJ; Wu JC; Garry MG; Zhang J; Garry DJ
J Am Coll Cardiol; 2020 Mar; 75(10):1159-1174. PubMed ID: 32164890
[TBL] [Abstract][Full Text] [Related]
16. A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells.
Young CS; Hicks MR; Ermolova NV; Nakano H; Jan M; Younesi S; Karumbayaram S; Kumagai-Cresse C; Wang D; Zack JA; Kohn DB; Nakano A; Nelson SF; Miceli MC; Spencer MJ; Pyle AD
Cell Stem Cell; 2016 Apr; 18(4):533-40. PubMed ID: 26877224
[TBL] [Abstract][Full Text] [Related]
17. Restoring Dystrophin Expression with Duchenne Muscular Dystrophy Exon 45 Skipping in Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Sato M; Shiba N; Miyazaki D; Shiba Y; Nakamura A
Methods Mol Biol; 2023; 2587():141-151. PubMed ID: 36401028
[TBL] [Abstract][Full Text] [Related]
18. Generation of Induced Pluripotent Stem Cells From Patients With Duchenne Muscular Dystrophy and Their Induction to Cardiomyocytes.
Hashimoto A; Naito AT; Lee JK; Kitazume-Taneike R; Ito M; Yamaguchi T; Nakata R; Sumida T; Okada K; Nakagawa A; Higo T; Kuramoto Y; Sakai T; Tominaga K; Okinaga T; Kogaki S; Ozono K; Miyagawa S; Sawa Y; Sakata Y; Morita H; Umezawa A; Komuro I
Int Heart J; 2016; 57(1):112-7. PubMed ID: 26673445
[TBL] [Abstract][Full Text] [Related]
19. IPSC derived cardiac fibroblasts of DMD patients show compromised actin microfilaments, metabolic shift and pro-fibrotic phenotype.
Soussi S; Savchenko L; Rovina D; Iacovoni JS; Gottinger A; Vialettes M; Pioner JM; Farini A; Mallia S; Rabino M; Pompilio G; Parini A; Lairez O; Gowran A; Pizzinat N
Biol Direct; 2023 Jul; 18(1):41. PubMed ID: 37501163
[TBL] [Abstract][Full Text] [Related]
20. Full-Length Dystrophin Restoration via Targeted Exon Addition in DMD-Patient Specific iPSCs and Cardiomyocytes.
Xiao R; Zhou M; Wang P; Zeng B; Wu L; Hu Z; Liang D
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
